Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Mouse Cd59b but not Cd59a is upregulated to protect cells from complement attack in response to inflammatory stimulation

Genes & Immunity volume 16, pages 437–445 (2015)Cite this article

Subjects

Abstract

Universally expressed CD59 is the sole membrane complement regulatory protein that protects host cells from complement damage by restricting membrane attack complex assembly. The human gene encodes a single CD59, whereas the mouse gene encodes a duplicated CD59, comprising mCd59a and mCd59b, with distinct tissue distribution. Recently, we revealed that Sp1 regulates constitutive CD59 transcription and that canonical nuclear factor kappa light chain enhancer of activated B cells (NF-κB) and cyclic AMP-responsive element-binding protein (CREB) regulate inducible CD59 transcription. However, the mechanisms that underlie mCd59 regulation remain unclear. Here we demonstrate that Sp1 controls broadly distributed mCd59a expression, whereas serum response factor (SRF) and canonical NF-κB regulate selectively expressed mCd59b. Tumor necrosis factor-α in vitro and lipopolysaccharide in vivo remarkably enhance the expression of mCd59b but not mCd59a by activating SRF and NF-κB, thus protecting cells from complement attack. In addition, cAMP analog treatment also dramatically increases mCd59b but not mCd59a expression in a manner independent of CREB, SRF and NF-κB. Therefore, mCd59b but not mCd59a may be the responder to external inflammatory stimuli and may have an important role in complement-mediated mouse models of disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Morgan BP, Marchbank KJ, Longhi MP, Harris CL, Gallimore AM . Complement: central to innate immunity and bridging to adaptive responses. Immunol Lett 2005; 97: 171–179.

    Article  CAS  PubMed  Google Scholar 

  2. Dunkelberger JR, Song WC . Complement and its role in innate and adaptive immune responses. Cell Res 2010; 20: 34–50.

    Article  CAS  PubMed  Google Scholar 

  3. Papadimitriou JC, Ramm LE, Drachenberg CB, Trump BF, Shin ML . Quantitative analysis of adenine nucleotides during the prelytic phase of cell death mediated by C5b-9. J Immunol 1991; 147: 212–217.

    CAS  PubMed  Google Scholar 

  4. Esser AF . The membrane attack complex of complement. Assembly, structure and cytotoxic activity. Toxicology 1994; 87: 229–247.

    Article  CAS  PubMed  Google Scholar 

  5. Ollert MW, Kadlec JV, David K, Petrella EC, Bredehorst R, Vogel CW . Antibody-mediated complement activation on nucleated cells. A quantitative analysis of the individual reaction steps. J Immunol 1994; 153: 2213–2221.

    CAS  PubMed  Google Scholar 

  6. Zhou X, Hu W, Qin X . The role of complement in the mechanism of action of rituximab for B-cell lymphoma: implications for therapy. Oncologist 2008; 13: 954–966.

    Article  CAS  PubMed  Google Scholar 

  7. Powell MB, Marchbank KJ, Rushmere NK, van den Berg CW, Morgan BP . Molecular cloning, chromosomal localization, expression, and functional characterization of the mouse analogue of human CD59. J Immunol 1997; 158: 1692–1702.

    CAS  PubMed  Google Scholar 

  8. Qian YM, Qin X, Miwa T, Sun X, Halperin JA, Song WC . Identification and functional characterization of a new gene encoding the mouse terminal complement inhibitor CD59. J Immunol 2000; 165: 2528–2534.

    Article  CAS  PubMed  Google Scholar 

  9. Meri S, Waldmann H, Lachmann PJ . Distribution of protectin (CD59), a complement membrane attack inhibitor, in normal human tissues. Lab Invest 1991; 65: 532–537.

    CAS  PubMed  Google Scholar 

  10. Baalasubramanian S, Harris CL, Donev RM, Mizuno M, Omidvar N, Song WC et al. CD59a is the primary regulator of membrane attack complex assembly in the mouse. J Immunol 2004; 173: 3684–3692.

    Article  CAS  PubMed  Google Scholar 

  11. Harris CL, Hanna SM, Mizuno M, Holt DS, Marchbank KJ, Morgan BP . Characterization of the mouse analogues of CD59 using novel monoclonal antibodies: tissue distribution and functional comparison. Immunology 2003; 109: 117–126.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Donev RM, Sivasankar B, Mizuno M, Morgan BP . The mouse complement regulator CD59b is significantly expressed only in testis and plays roles in sperm acrosome activation and motility. Mol Immunol 2008; 45: 534–542.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Qin X, Miwa T, Aktas H, Gao M, Lee C, Qian YM et al Genomic structure, functional comparison, and tissue distribution of mouse Cd59a and Cd59b. Mamm Genome 2001; 12: 582–589.

    Article  CAS  PubMed  Google Scholar 

  14. Qin X, Dobarro M, Bedford SJ, Ferris S, Miranda PV, Song W et al. Further characterization of reproductive abnormalities in mCd59b knockout mice: a potential new function of mCd59 in male reproduction. J Immunol 2005; 175: 6294–6302.

    Article  CAS  PubMed  Google Scholar 

  15. Zhang J, Hu W, Xing W, You T, Xu J, Qin X et al. The protective role of CD59 and pathogenic role of complement in hepatic ischemia and reperfusion injury. Am J Pathol 2011; 179: 2876–2884.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wu G, Hu W, Shahsafaei A, Song W, Dobarro M, Sukhova GK et al. Complement regulator CD59 protects against atherosclerosis by restricting the formation of complement membrane attack complex. Circ Res 2009; 104: 550–558.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ruiz-Arguelles A, Llorente L . The role of complement regulatory proteins (CD55 and CD59) in the pathogenesis of autoimmune hemocytopenias. Autoimmun Rev 2007; 6: 155–161.

    Article  CAS  PubMed  Google Scholar 

  18. Krus U, King BC, Nagaraj V, Gandasi NR, Sjolander J, Buda P et al. The complement inhibitor CD59 regulates insulin secretion by modulating exocytotic events. Cell Metab 2014; 19: 883–890.

    Article  CAS  PubMed  Google Scholar 

  19. Du Y, Teng X, Wang N, Zhang X, Chen J, Ding P et al. NF-kappaB and enhancer-binding CREB protein scaffolded by CREB-binding protein (CBP)/p300 proteins regulate CD59 protein expression to protect cells from complement attack. J Biol Chem 2014; 289: 2711–2724.

    Article  CAS  PubMed  Google Scholar 

  20. Qin X, Ferris S, Hu W, Guo F, Ziegeler G, Halperin JA . Analysis of the promoters and 5'-UTR of mouse Cd59 genes, and of their functional activity in erythrocytes. Genes Immun 2006; 7: 287–297.

    Article  CAS  PubMed  Google Scholar 

  21. Pangburn MK, Morrison DC, Schreiber RD, Muller-Eberhard HJ . Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b. J Immunol 1980; 124: 977–982.

    CAS  PubMed  Google Scholar 

  22. Madonna R, Geng YJ, Bolli R, Rokosh G, Ferdinandy P, Patterson C et al. Co-Activation of nuclear factor-kappab and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts. J Biol Chem 2014; 289: 19585–19598.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Li YP, Schwartz RJ . TNF-alpha regulates early differentiation of C2C12 myoblasts in an autocrine fashion. FASEB J 2001; 15: 1413–1415.

    Article  CAS  PubMed  Google Scholar 

  24. Wells MJ, Hatton MW, Hewlett B, Podor TJ, Sheffield WP, Blajchman MA . Cytokeratin 18 is expressed on the hepatocyte plasma membrane surface and interacts with thrombin-antithrombin complexes. J Biol Chem 1997; 272: 28574–28581.

    Article  CAS  PubMed  Google Scholar 

  25. Bonizzi G, Karin M . The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 2004; 25: 280–288.

    Article  CAS  PubMed  Google Scholar 

  26. Oeckinghaus A, Hayden MS, Ghosh S . Crosstalk in NF-kappaB signaling pathways. Nat Immunol 2011; 12: 695–708.

    Article  CAS  PubMed  Google Scholar 

  27. Hayden MS, Ghosh S . NF-kappaB in immunobiology. Cell Res 2011; 21: 223–244.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Baeuerle PA, Henkel T . Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 1994; 12: 141–179.

    Article  CAS  PubMed  Google Scholar 

  29. Kanarek N, London N, Schueler-Furman O, Ben-Neriah Y . Ubiquitination and degradation of the inhibitors of NF-kappaB. Cold Spring Harb Perspect Biol 2010; 2: a000166.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Chai J, Tarnawski AS . Serum response factor: discovery, biochemistry, biological roles and implications for tissue injury healing. J Physiol Pharmacol 2002; 53: 147–157.

    CAS  PubMed  Google Scholar 

  31. Arsenian S, Weinhold B, Oelgeschlager M, Ruther U, Nordheim A . Serum response factor is essential for mesoderm formation during mouse embryogenesis. EMBO J 1998; 17: 6289–6299.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Taylor A, Tang W, Bruscia EM, Zhang PX, Lin A, Gaines P et al. SRF is required for neutrophil migration in response to inflammation. Blood 2014; 123: 3027–3036.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Xie L, Sullivan AL, Collier JG, Glass CK . Serum response factor indirectly regulates type I interferon-signaling in macrophages. J Interferon Cytokine Res 2013; 33: 588–596.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Badea TD, Park JH, Soane L, Niculescu T, Niculescu F, Rus H et al. Sublytic terminal complement attack induces c-fos transcriptional activation in myotubes. J Neuroimmunol 2003; 142: 58–66.

    Article  CAS  PubMed  Google Scholar 

  35. Kilgore KS, Schmid E, Shanley TP, Flory CM, Maheswari V, Tramontini NL et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol 1997; 150: 2019–2031.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Tan NY, Khachigian LM . Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol 2009; 29: 2483–2488.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Philipsen S, Suske G . A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res 1999; 27: 2991–3000.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Bouwman P, Philipsen S . Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol 2002; 195: 27–38.

    Article  CAS  PubMed  Google Scholar 

  39. Chuang JY, Wang YT, Yeh SH, Liu YW, Chang WC, Hung JJ . Phosphorylation by c-Jun NH2-terminal kinase 1 regulates the stability of transcription factor Sp1 during mitosis. Mol Biol Cell 2008; 19: 1139–1151.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Hu W, Ge X, You T, Xu T, Zhang J, Wu G et al. Human CD59 inhibitor sensitizes rituximab-resistant lymphoma cells to complement-mediated cytolysis. Cancer Res 2011; 71: 2298–2307.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This research was supported by grants to WH from the National Natural Science Foundation of China (81171910, 81372258), the Major State Basic Research Development Program of China (2013CB910802) and the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning.

Author information

Authors and Affiliations

  1. Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Collaborative Innovation Center of Cancer Medicine, Shanghai Medical College, Fudan University, Shanghai, China

    J Chen, Y Du, P Ding, X Zhang, L Zhang, N Wang & W Hu

  2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

    J Chen, Y Du, P Ding, X Zhang, L Zhang, N Wang & W Hu

  3. Department of Immunology, Shanghai Medical College, Fudan University, Shanghai, China

    W Hu

Authors
  1. J Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y Du
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. X Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. N Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. W Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W Hu.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on Genes and Immunity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, J., Du, Y., Ding, P. et al. Mouse Cd59b but not Cd59a is upregulated to protect cells from complement attack in response to inflammatory stimulation. Genes Immun 16, 437–445 (2015). https://doi.org/10.1038/gene.2015.29

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gene.2015.29

Search

Advanced search

Quick links